Alerts will be sent to your verified email
Verify EmailSANOFICONR
|
Sanofi Cons. Health
|
Viyash Scientific
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
72.87 % | 4.43 % | 30.1 % |
|
5yr average Equity Multiplier
|
1.82 | 2.16 | 2.62 |
|
5yr Average Asset Turnover Ratio
|
1.48 | 0.95 | 0.6 |
|
5yr Avg Net Profit Margin
|
27.34 % | 0.03 % | 12.9 % |
|
Price to Book
|
28.25 | 3.72 | 3.39 |
|
P/E
|
42.06 | 61.05 | 18.93 |
|
5yr Avg Cash Conversion Cycle
|
-83.69 Days | 49.09 Days | -51.45 Days |
|
Inventory Days
|
47.09 Days | 80.25 Days | 69.05 Days |
|
Days Receivable
|
10.93 Days | 79.76 Days | 60.35 Days |
|
Days Payable
|
135.97 Days | 114.46 Days | 225.58 Days |
|
5yr Average Interest Coverage Ratio
|
32.14 | 1.93 | 0.72 |
|
5yr Avg ROCE
|
99.14 % | 6.67 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
38.38 % | 7.74 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.53 | 1.01 |
|
5yr CAGR Net Profit
|
1.88 % | -25.52 % | 68.01 % |
|
5yr Average Return on Assets
|
40.56 % | 0.05 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.27 % | 61.31 % | 27.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 27.27 % |
|
Change in Promoter Holding (3 Yrs)
|
10.87 % | 8.52 % | -0.36 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.57 % | 6.19 % | -2.58 % |
|
Sanofi Cons. Health
|
Viyash Scientific
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|